Conferences - Results from #8600

ASCO - Docetaxel and/or zoledronic acid for hormone-naïve prostate cancer: First overall survival results from STAMPEDE - Session Highlights June 3, 2015

ASCO - Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration resistant prostate cancer - Session Highlights June 2, 2015

ASCO - ARAMIS: Novel oral androgen receptor inhibitor ODM-201 enters phase 3 study in nmCRPC - Session Highlights June 2, 2015

#ASCO15 - ODM-201 demonstrates high anticancer activity and favorable tolerability in the ARADES phase I/II trial in mCRPC - Session Highlights June 2, 2015

ASCO 2015 - Long-term consequences of intermittent and continuous androgen deprivation in men with metastatic prostate cancer - Session Highlights June 2, 2015

ASCO - Radium-223 provides pain relief for patients with CRPC and bone metastases - Session Highlights June 1, 2015

ASCO - Timing of radium-223 in today’s treatment landscape - Session Highlights June 1, 2015

ASCO - Now or later: Optimal timing of docetaxel for metastatic prostate cancer: Early treatment with docetaxel chemotherapy - Session Highlights June 1, 2015

ASCO - Now or later: Optimal timing of docetaxel for metastatic prostate cancer: Late treatment with docetaxel chemotherapy - Session Highlights June 1, 2015

ASCO - Bottom line: Timing of treatment with docetaxel for men with advanced prostate cancer - Session Highlights June 1, 2015

ASCO - Radium-223 linked to longer overall survival in international study of mCRPC patients with bone metastases - Session Highlights June 1, 2015

ASCO - Radium-223 early access program (EAP) enlightens safety, tolerability profile in a U.S. population of CRPC patients - Session Highlights June 1, 2015

#AUA15 - After 15 years, former smokers can lower their risk of recurrence of non-muscle invasive bladder cancer - Session Highlights May 26, 2015

#AUA15 - Futuristic stone “dusting” reduces kidney stones to a fine powder - Session Highlights May 26, 2015

#AUA15 - Older patients’ UTI symptoms may predict for bladder cancer, especially among women - Session Highlights May 21, 2015

#AUA15 - Active surveillance in Sweden: An example to follow? - Session Highlights May 21, 2015

#AUA15 - Point-Counterpoint: Refractory overactive bladder (OAB) with pelvic organ prolapse (POP) - Session Highlights May 20, 2015

#AUA15 - Durable reductions in urinary incontinence with long-term onabotulinumtoxinA treatment in patients with overactive bladder syndrome: Final results of 3.5-year study - Session Highlights May 20, 2015

#AUA15 - AUA Guideline: Interstitial cystitis guideline amendment - Session Highlights May 20, 2015

#AUA15 - Can multiparametric magnetic resonance imaging predict biochemical recurrence after radical prostatectomy? Implications for preoperative staging and surgical planning - Session Highlights May 20, 2015

Page 431 of 507